IL-18 Production Downstream of the Nlrp3 Inflammasome Confers Protection against Colorectal Tumor Formation
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Colorectal cancer is a leading cause of cancer-related deaths worldwide. Chronic inflammation is recognized as a predisposing factor for the development of colon cancer, but the molecular mechanisms linking inflammation and tumorigenesis have remained elusive. Recent studies revealed a crucial role for the NOD-like receptor protein Nlrp3 in regulating inflammation through the assembly of proinflammatory protein complexes termed inflammasomes. However, its role in colorectal tumor formation remains unclear. In this study, we showed that mice deficient for Nlrp3 or the inflammasome effector caspase-1 were highly susceptible to azoxymethane/dextran sodium sulfate-induced inflammation and suffered from dramatically increased tumor burdens in the colon. This was a consequence of markedly reduced IL-18 levels in mice lacking components of the Nlrp3 inflammasome, which led to impaired production and activation of the tumor suppressors IFN-γ and STAT1, respectively. Thus, IL-18 production downstream of the Nlrp3 inflammasome is critically involved in protection against colorectal tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies using different mice deficient for inflammasomes components (including NLRP3, NLRP1, NLRP6, NLRC4 and Caspase-1) found that the inflammasomes protect mice from colitis-associated CRC [120,121,122,123,124].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Experimental — accuracy not yet measuredIn the citing paper
“In fact, IL-18 KO or IL-18R KO mice are also highly sensitive to colitis-associated CRC [124,125].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 1×
“The synthesis and secretion of these cytokines is controlled by transcription factors of the STAT, NF-kB, and AP-1 families (6).”
BackgroundDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 1×
“in the NLR protein NOD2 are linked with the development of Crohn’s disease in humans (41, 42).”
BackgroundA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030 · cited 1×
“in the NLR protein NOD2 are linked with the development of Crohn’s disease in humans (41, 42).”
BackgroundNuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896 · cited 1×
“Indeed, IL-18 was originally identified as the “IFN-g–inducing factor” (22), and IFN-g has been described as a pleiotropic cytokine with potent antitumor activity (34, 37).”
BackgroundCELLULAR RESPONSES TO INTERFERON-γ
Boehm, U., Klamp, T., Groot, M., & Howard, J. C. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.749 · Cited by 2,890
Cited by
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368
“IL18 plays an essential role in suppression of colonic inflammation and inflammation-associated cancers (Chen et al., 2011; Dupaul-Chicoine et al., 2010; Elinav et al., 2011; Salcedo et al., 2010; Zaki et al., 2010).”
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
Garrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
NLRP3 inflammasome in cancer and metabolic diseases
Sharma, B. R., & Kanneganti, T.-D. (2021) · Nature Immunology · doi:10.1038/s41590-021-00886-5 · Cited by 1,097
Self-citationRegulation of inflammasome activation
Man, S. M., & Kanneganti, T. (2015) · Immunological Reviews · doi:10.1111/imr.12296 · Cited by 1,064
Self-citationInflammasomes and Their Roles in Health and Disease
Lamkanfi, M., & Dixit, V. M. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155745 · Cited by 935
Self-citationMechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
Converging roles of caspases in inflammasome activation, cell death and innate immunity
Man, S. M., & Kanneganti, T.-D. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.7 · Cited by 701
Self-citationDiverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
Self-citationInflammasomes in carcinogenesis and anticancer immune responses
Zitvogel, L., Kepp, O., Galluzzi, L., & Kroemer, G. (2012) · Nature Immunology · doi:10.1038/ni.2224 · Cited by 593
Blevins, H. M., Xu, Y., Biby, S., & Zhang, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.879021 · Cited by 587
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
“Further studies are needed to assess whether inflammasomes and/or IL-18 inhibit CRC development in genetic CRC models (such as the APC/min mice), as well as in human CRC. Relevantly, Lactobacilli are able to activate the inflammasomes in human primary macrophages, as well as in primary mammalian gut epithelial cells,…”
BackgroundInfluentialBenefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
Sivaprakasam, S., Prasad, P. D., & Singh, N. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.007 · Cited by 571
Interleukin-18 in Health and Disease
Yasuda, K., Nakanishi, K., & Tsutsui, H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030649 · Cited by 563
“Intriguingly, treatment with exogenous recombinant IL-18 restored epithelial permeability, colitis, and the tumor burden [291].”
BackgroundAllen, I. C., Wilson, J. E., Schneider, M., Lich, J. D., Roberts, R. A., Arthur, J. C., Woodford, R.-M. T., Davis, B. K., Uronis, J. M., Herfarth, H. H., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.012 · Cited by 534
“NOD1 and NLRP3 have a significant protective role in mediating EC and CAC in animals (Allen et al. 2010; Chen et al. 2008; Zaki et al. 2010).”
A functional role for NLRP6 in intestinal inflammation and tumorigenesis
Chen, G. Y., Liu, M., Wang, F., Bertin, J., & Núñez, G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100412 · Cited by 436
Role of the NLRP3 inflammasome in cancer
Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 417
Emerging cytokine networks in colorectal cancer
West, N. R., McCuaig, S., Franchini, F., & Powrie, F. (2015) · Nature Reviews Immunology · doi:10.1038/nri3896 · Cited by 396
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
Menu, P., & Vince, J. E. (2011) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2011.04440.x · Cited by 389
NLRP6 Protects Il10 Mice from Colitis by Limiting Colonization of Akkermansia muciniphila
Seregin, S. S., Golovchenko, N., Schaf, B., Chen, J., Pudlo, N. A., Mitchell, J., Baxter, N. T., Zhao, L., Schloss, P. D., Martens, E. C., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.080 · Cited by 386
Karki, R., Man, S. M., & Kanneganti, T.-D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0269 · Cited by 377
“In addition to NLRs, the DNA-sensing inflammasome sensor AIM2 can inhibit AOM-DSS–induced and spontaneous colorectal tumorigenesis via an inflammasome-independent mechanism (refs.”
Self-citationNormand, S., Delanoye-Crespin, A., Bressenot, A., Huot, L., Grandjean, T., Peyrin-Biroulet, L., Lemoine, Y., Hot, D., & Chamaillard, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100981108 · Cited by 355
NOD-Like Receptors: Versatile Cytosolic Sentinels
Motta, V., Soares, F., Sun, T., & Philpott, D. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00009.2014 · Cited by 353
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Irrazábal, T., Belcheva, A., Girardin, S. E., Martin, A., & Philpott, D. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.039 · Cited by 344
“…(de Kok et al., 1992), and a number of in vitro and in vivo studies have confirmed that fecapentaenes induce oxidative DNA damage through generation of 8-oxo-dG or directly alkylate DNA to form secondary mutagenic species (Huycke and Gaskins, 2004; Shioya et al., 1989; Zarkovic et al., 1993).”
BackgroundDupaul-Chicoine, J., Arabzadeh, A., Dagenais, M., Douglas, T., Champagne, C., Morizot, A., Rodrigue-Gervais, I. G., Breton, V., Colpitts, S. L., Beauchemin, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.013 · Cited by 342
“…Il-18 or Il-18r, exhibit increased colitis and tumorigenesis compared to wild-type (WT) mice in the azoxymethane-dextran sulfate sodium (AOM-DSS) model (Allen et al., 2010; Dupaul-Chicoine et al., 2010; Elinav et al., 2011; Huber et al., 2012; Salcedo et al., 2010; Zaki et al., 2010a, 2010b).”
BackgroundCritical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
Man, S. M., Zhu, Q., Zhu, L., Liu, Z., Karki, R., Malik, A., Sharma, D., Li, L., Malireddi, R. K. S., Gurung, P., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.001 · Cited by 327
Self-citationThe role of inflammasomes in kidney disease
Komada, T., & Muruve, D. A. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0158-z · Cited by 304
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
“DAMPs and PAMPs are sensed by inflammasomes [183] [184] [185] 187, 188, 204 .”
BackgroundInfluentialMolecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Hou, J., Hsu, J.-M., & Hung, M.-C. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.003 · Cited by 301
Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt
Wilson, J. E., Petrucelli, A. S., Chen, L., Koblansky, A. A., Truax, A. D., Oyama, Y., Rogers, A. B., Brickey, W. J., Wang, Y., Schneider, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3908 · Cited by 294
Deregulation of the NLRP3 inflammasome in hepatic parenchymal cells during liver cancer progression
Wei, Q., Mu, K., Li, T., Zhang, Y., Yang, Z., Jia, X., Zhao, W., Huai, W., Guo, P., & Han, L. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2013.126 · Cited by 291
The NLRP3 inflammasome: Contributions to intestinal homeostasis
Zaki, M. H., Lamkanfi, M., & Kanneganti, T.-D. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.002 · Cited by 290
Self-citationInflammasomes in cancer: a double-edged sword
Kolb, R., Liu, G.-H., Janowski, A. M., Sutterwala, F. S., & Zhang, W. (2014) · Protein & Cell · doi:10.1007/s13238-013-0001-4 · Cited by 287
“NLRP6, another NLR family member, can also suppress tumorigenesis in the AOM/DSS CAC model, likely through secretion of IL-18 from hematopoietic cells (Chen et al., 2011), or regulation of wound healing by myofibroblasts (Normand et al., 2011).”
InfluentialInterferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
Karki, R., Sharma, B. R., Lee, E., Banoth, B., Malireddi, R. K. S., Samir, P., Tuladhar, S., Mummareddy, H., Burton, A. R., Vogel, P., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136720 · Cited by 282
“that IRF1 provides protection against CAC independent of IL-18 signaling (54, 55).”
BackgroundSelf-citationNLR functions beyond pathogen recognition
Kufer, T. A., & Sansonetti, P. J. (2011) · Nature Immunology · doi:10.1038/ni.1985 · Cited by 279
Gao, J., Qiu, X., Xi, G., Liu, H., Zhang, F., Lv, T., & Song, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6634 · Cited by 275
“For example, mice lacking NLRP3 are reported to be hypersusceptible to colitis-associated colorectal cancer as shown by several studies (16,17), whereas another study demonstrated that a lack of NLRP3 attenuated DSS-induced colitis in mice (18).”
NOD-Like Receptors: Master Regulators of Inflammation and Cancer
Saxena, M., & Yeretssian, G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00327 · Cited by 274
“Overall, NLRP3 was shown to be important for IL-18 secretion, which in turn through IFNγ production induces STAT1 (Signal transducers and activators of transcription 1) phosphorylation and thus promotes an anti-tumorigenic environment (200).”
BackgroundKarki, R., Man, S. M., Malireddi, R. K. S., Gurung, P., Vogel, P., Lamkanfi, M., & Kanneganti, T.-D. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.006 · Cited by 272
“Mice Aim2 / , Nlrp3 / , Asc / , Casp1 / Casp11 / , Casp11 / , Casp1 / Casp11, Nlrc4 / , Nod1 / , Il1b / , Il18 / , Rip3 / , Rip3 / Casp8 / , and Rip3 / Fadd / mice were described previously (Jones et al., 2010; Kanneganti et al., 2006; Kayagaki et al., 2011; Mariathasan et al., 2004, 2006; Oberst et al., 2011; Shornic…”
Self-citationBioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
“[98] have demonstrated that caspase-1-deficient mice have increased the number of tumors, similar to NLRP3 mutants, which is associated with a decreased production of IL-18 and activation of STAT1.”
BackgroundHarnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
The role of pattern recognition receptors in intestinal inflammation
Fukata, M., & Arditi, M. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.13 · Cited by 253
“The major defect in these NLR-deficient mice lies in the regulation of epithelial cell proliferation, as these mice demonstrate increased proliferation of IECs during AOMDSS treatment.(61,76,85,114) Similar increase in IEC proliferation during intestinal tumorigenesis has been reported in caspase-1 / and NOD1 / mice.”
BackgroundInfluentialGut microbiota, host health, and polysaccharides
Xu, X., Xu, P., Ma, C., Tang, J., & Zhang, X. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.12.009 · Cited by 245
“IL-18 has been implicated in protecting against colorectal tumorigenesis (Salcedo et al., 2010; Zaki et al., 2010b).”
Mitophagy in tumorigenesis and metastasis
Poole, L. P., & Macleod, K. F. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03774-1 · Cited by 241
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Lee, H., Zhang, P., Herrmann, A., Yang, C., Xin, H., Wang, Z., Hoon, D. S. B., Forman, S. J., Jove, R., Riggs, A. D., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205132109 · Cited by 234
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
Hamarsheh, S., & Zeiser, R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01444 · Cited by 230
Inflammasomes as therapeutic targets in human diseases
Li, Y., Huang, H., Liu, B., Zhang, Y., Pan, X., Yu, X.-Y., Shen, Z., & Song, Y.-H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00650-z · Cited by 223
Cytokine-Induced Modulation of Colorectal Cancer
Mager, L. F., Wasmer, M.-H., Rau, T. T., & Krebs, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00096 · Cited by 216
“Indeed, Il18−/− mice showed a more severe clinical and histopathological manifestation of colitis than WT animals upon challenge with DSS, a phenotype recapitulated in Nlrp3−/− or Casp1−/− mice (153).”
BackgroundNLRC3 is an inhibitory sensor of PI3K–mTOR pathways in cancer
Karki, R., Man, S. M., Malireddi, R. K. S., Kesavardhana, S., Zhu, Q., Burton, A. R., Sharma, B. R., Qi, X., Pelletier, S., Vogel, P., et al. (2016) · Nature · doi:10.1038/nature20597 · Cited by 213
Self-citationRimessi, A., Previati, M., Nigro, F., Wieckowski, M. R., & Pinton, P. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.015 · Cited by 210
Exploiting bacteria for cancer immunotherapy
Kwon, S.-Y., Thi-Thu Ngo, H., Son, J., Hong, Y., & Min, J.-J. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00908-9 · Cited by 201
NOD-like receptors and the innate immune system: Coping with danger, damage and death
Kersse, K., Bertrand, M. J. M., Lamkanfi, M., & Vandenabeele, P. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.003 · Cited by 201
“In cancer, the inflammasomes appear to function as tumor-suppressing complexes because, at least in a colitis-associated colorectal cancer model, they limit tumor burden [86,105,117,123,124].”
BackgroundSelf-citationMalik, A., Sharma, D., Malireddi, R. K. S., Guy, C. S., Chang, T.-C., Olsen, S. R., Neale, G., Vogel, P., & Kanneganti, T.-D. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.024 · Cited by 196
“Inflammasome activation is one such critical aspect of innate immunity that has been shown to modulate colitis and CRC pathogenesis (Zaki et al., 2010b).”
Self-citationYao, X., Zhang, C., Xing, Y., Xue, G., Zhang, Q., Pan, F., Wu, G., Hu, Y., Guo, Q., Lu, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01917-2 · Cited by 195
Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Qiu, Y.-Y., & Tang, L.-Q. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.004 · Cited by 195
Microleakage of posterior packable resin composites with and without flowable liners.
Leevailoj, C., Cochran, M. A., Matis, B. A., Moore, B. K., & Platt, J. A. (2001) · PubMed · Cited by 193
Shao, W., Yang, Z., Fu, Y., Zheng, L., Liu, F., Chai, L., & Jia, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.676485 · Cited by 190
“It has the effect of inhibiting tumor growth in colorectal cancer, liver cancer, and skin cancer (Zaki et al., 2010; Ellis et al., 2011; Ma et al., 2016), but a two-way effect in breast cancer (Chen et al., 2012).”
BackgroundInflammasome, Inflammation, and Tissue Homeostasis
Rathinam, V. A. K., & Chan, F. K.-M. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.01.004 · Cited by 190
The interplay between autophagy and ROS in tumorigenesis
Kongara, S., & Karantza, V. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00171 · Cited by 184
NLRP3 Suppresses NK Cell–Mediated Responses to Carcinogen-Induced Tumors and Metastases
Chow, M. T., Sceneay, J., Paget, C., Wong, C. S. F., Duret, H., Tschopp, J., Möller, A., & Smyth, M. J. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0509 · Cited by 182
“tumorigenesis (17, 20) and stimulating antitumor immunity Authors' Affiliations: (1)Cancer Immunology Program, (2)Cancer Genomics and Genetics Laboratory, Peter MacCallum Cancer Centre, St.”
BackgroundContext-dependent role of IL-18 in cancer biology and counter-regulation by IL-18BP
Fabbi, M., Carbotti, G., & Ferrini, S. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ru0714-360rr · Cited by 177
“Indeed, IL-18 administration to Casp1 mice reduces the signs of colitis and epithelial cell dysplasia and restores pSTAT1 [49].”
BackgroundIL-33 regulates the IgA-microbiota axis to restrain IL-1α–dependent colitis and tumorigenesis
Malik, A., Sharma, D., Zhu, Q., Karki, R., Guy, C. S., Vogel, P., & Kanneganti, T.-D. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88625 · Cited by 175
“tumorigenesis has been described previously (61).”
Self-citationVisekruna, A., & Luu, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703218 · Cited by 174
Inflammasomes in Intestinal Inflammation and Cancer
Chen, G. Y., & Núñez, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.10.002 · Cited by 150
Zhang, J., Zhang, J., Zhang, Y., Liu, W., Ni, W., Huang, X., Yuan, J., Zhao, B., Xiao, H., & Xue, F. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15784 · Cited by 169
Deregulated inflammasome signaling in disease
Lamkanfi, M., Walle, L. V., & Kanneganti, T. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01042.x · Cited by 155
“Given that gut inflammation is an important predisposing factor for the development of colorectal cancer (100), mice lacking components of the Nlrp3 inflammasome were also subjected to the azoxymethane (AOM) ⁄ DSS tumorigenesis model (56, 92).”
BackgroundMethodInfluentialSelf-citationChen, L., Huang, C., Li, Y., Deng, W., Mao, L., Wu, L., Zhang, W., Zhang, L., & Sun, Z. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2720-9 · Cited by 168
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
The Gastrointestinal Tumor Microenvironment
Quante, M., Varga, J., Wang, T. C., & Greten, F. R. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.03.052 · Cited by 151
How Inflammasomes Inform Adaptive Immunity
Evavold, C. L., & Kagan, J. C. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.09.019 · Cited by 144
“One study has shown that reduction of IL-18 through loss of NLRP3 leads to a reduction of IFN-γ production in the gut [224].”
Zhu, Q., Man, S. M., Gurung, P., Liu, Z., Vogel, P., Lamkanfi, M., & Kanneganti, T.-D. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402051 · Cited by 153
“CRC development by modulating IL-18 production (15, 16).”
Self-citationThe NLRP1 inflammasome attenuates colitis and colitis-associated tumorigenesis
Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402098 · Cited by 162
“other NLR inflammasome-deficient mouse strains (13).”
Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis
Sharma, D., Malik, A., Guy, C. S., Karki, R., Vogel, P., & Kanneganti, T.-D. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.276 · Cited by 162
Self-citationRatsimandresy, R. A., Indramohan, M., Dorfleutner, A., & Stehlik, C. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.35 · Cited by 161
Zhou, C., & Fang, J. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.001 · Cited by 161
Gabarin, R., Li, M., Zimmel, P. A., Marshall, J. C., Li, Y., & Zhang, H. (2021) · Journal of Innate Immunity · doi:10.1159/000515740 · Cited by 158
NF-κB: a double-edged sword controlling inflammation
Liu, D., Zhong, Z., & Karin, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061250 · Cited by 157
Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
Lopetuso, L. R., Chowdhry, S., & Pizarro, T. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00181 · Cited by 133
“Furthermore, administration of exogenous IL-18 can alleviate the severity of colitis and colitis-induced tumorigenesis in caspase-1/11 and Nlrp3 KO mice (148).”
BackgroundUngerbäck, J., Belenki, D., Jawad ul-Hassan, A., Fredrikson, M., Fransén, K., Elander, N., Verma, D., & Söderkvist, P. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs256 · Cited by 140
Huang, C., Chen, L., Li, Y., Wu, L., Yu, G., Zhang, W., & Sun, Z. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0589-y · Cited by 152
“IL-18 production downstream of the NLRP3 inflammasome is critically involved in the protection against colorectal tumorigenesis [14].”
BackgroundContext-dependent functions of pattern recognition receptors in cancer
Man, S. M., & Jenkins, B. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00462-5 · Cited by 151
Advances in Understanding Activation and Function of the NLRC4 Inflammasome
Sundaram, B., & Kanneganti, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031048 · Cited by 144
Self-citationEmerging mechanisms of pyroptosis and its therapeutic strategy in cancer
Lu, L., Zhang, Y., Tan, X., Merkher, Y., Leonov, S. V., Zhu, L., Deng, Y., zhang, H., Zhu, D., Tan, Y., et al. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01101-6 · Cited by 145
NOD-like receptors: major players (and targets) in the interface between innate immunity and cancer
Velloso, F. J., Trombetta-Lima, M., Anschau, V., Sogayar, M. C., & Correa, R. G. (2019) · Bioscience Reports · doi:10.1042/bsr20181709 · Cited by 134
Inflammasomes and intestinal inflammation
Zmora, N., Levy, M., Pevsner-Fishcer, M., & Elinav, E. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.19 · Cited by 139
“NLRP3-deficient mice featured increased propensity to develop colitis-associated tumors in the azoxymethane (AOM)-DSS model, mediated by NLRP3 deficiency in hematopoietic cells.(26,61) NLRP3 has been suggested to confer a protective role from colorectal cancer development in an IL-18-dependent manner, as recombinant I…”
BackgroundDifferential expression of inflammasomes in lung cancer cell lines and tissues
Kong, H., Wang, Y., Zeng, X., Wang, Z., Wang, H., & Xie, W. (2015) · Tumor Biology · doi:10.1007/s13277-015-3473-4 · Cited by 135
Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
Kantono, M., & Guo, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01132 · Cited by 133
“This conclusion is further supported by studies showing that IL-18 KO or IL-18R KO mice are also highly susceptible to DSS-induced colitis and AOM/DSS-induced colon cancer (82, 83).”
ResultYuan, Y., Xie, K.-X., Wang, S.-L., & Yuan, L. (2018) · Gastroenterology report · doi:10.1093/gastro/goy011 · Cited by 134
Hu, S., Peng, L., Kwak, Y.-T., Tekippe, E. M., Pasare, C., Malter, J. S., Hooper, L. V., & Zaki, M. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.040 · Cited by 121
“We and others previously demonstrated that the NLRP3 inflammasome regulates intestinal inflammation and tumorigenesis in mice (Allen et al., 2010; Hirota et al., 2011; Zaki et al., 2010a, 2010b).”
InfluentialLiu, R., Truax, A. D., Chen, L., Hu, P., Li, Z., Chen, J., Song, C., Chen, L., & Ting, J. P.-Y. (2015) · Oncotarget · doi:10.18632/oncotarget.5587 · Cited by 118
“However, in models of colitis-associated colorectal cancer IL-18 cytokine addback showed that IL-18 protected against tumor [28].”
Conforti‐Andreoni, C., Ricciardi‐Castagnoli, P., & Mortellaro, A. (2011) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.81 · Cited by 123
Неганова, М. Е., Liu, J., Aleksandrova, Y. R., Klochkov, S. G., & Fan, R. (2021) · Cancers · doi:10.3390/cancers13236062 · Cited by 120
Gut Microbiota Protects against Gastrointestinal Tumorigenesis Caused by Epithelial Injury
Zhan, Y., Chen, P.-J., Sadler, W. D., Wang, F., Poe, S., Núñez, G., Eaton, K. A., & Chen, G. Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0827 · Cited by 107
“For example, other bacterial sensingmechanisms such as through the NLRs are also important for promoting wound repair and curtailing aberrant inflammatory responses during colitis-associated tumorigenesis (5, 6, 19, 20, 22, 23, 38, 39).”
BackgroundCooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism
Ayres, J. S. (2016) · Cell · doi:10.1016/j.cell.2016.05.049 · Cited by 110
Interleukin-18: a regulator of cancer and autoimmune diseases
Esmaeilbeig, M., & Ghaderi, A. A. (2017) · European Cytokine Network · doi:10.1684/ecn.2018.0401 · Cited by 119
“showed that Nlrp3 inflammasome-dependent production of IL-18 possibly has a protective role against colorectal adenocarcinomas through IFN- production and STAT1 (signal transducer and activator of transcription 1) signaling [30].”
BackgroundNLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease
Tye, H., Yu, C.-H., Simms, L. A., de Zoete, M. R., Kim, M. L., Zakrzewski, M., Penington, J. S., Harapas, C. R., Souza-Fonseca-Guimaraes, F., Wockner, L. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06125-0 · Cited by 110
NLRP3 Inflammasome and Pathobiology in AMD
Celkova, L., Doyle, S., & Campbell, M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4010172 · Cited by 104
“In line with these findings, it was previously suggested that IL-18 might be protective in other diseases, such as experimental colitis and colorectal cancer in mice [95–98].”
ResultKey Aging-Associated Alterations in Primary Microglia Response to Beta-Amyloid Stimulation
Caldeira, C., Cunha, C., Vaz, A. R., Falcão, A. S., Barateiro, A., Seixas, E., Fernandes, A., & Brites, D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00277 · Cited by 117
Inflammasomes in Inflammation-Induced Cancer
Lin, C., & Zhang, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00271 · Cited by 120
“differences Interleukin-18 in CAC Early stage Enhanced colitis-induced proliferation (188, 189)”
Background
Metadata
- Authors
- Zaki, M. H., Vogel, P., Body-Malapel, M., Lamkanfi, M., & Kanneganti, T.-D.
- Affiliations
- Department of Immunology , Memphis, TN 38105
- St. Jude Children's Research Hospital (US)
- Department of Physiopathology of Inflammatory Bowel Diseases, INSERM Unité 995 , Lille ,
- Vlaams Instituut voor Biotechnologie (BE)
- Corresponding author
- Kanneganti, Thirumala-Devi
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 185
- Issue
- 8
- Pages
- 4912-4920
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3104023
- OpenAlex
- W1954263225
- Cited by
- 411
- References
- 62
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 39 · 2023: 26 · 2022: 42 · 2021: 43 · 2020: 20 · 2019: 30 · 2018: 26 · 2017: 24 · 2016: 22 · 2015: 26 · 2014: 18 · 2013: 25 · 2012: 20
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- Yale University
- St. Jude Children's Research Hospital
- American Lebanese Syrian Associated Charities (AR056296, CA 21765)
- Vlaamse regering
- National Institutes of Health (CA21765))
- Takeda Oncology
- National Cancer Institute (2 P30 CA21765, P30CA021765)
- National Institute of Allergy and Infectious Diseases (AI088177, R21AI088177)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056296, AR-056296)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Keywords
- IL-18, NLRP3 inflammasome, colorectal cancer, colorectal carcinogenesis, caspase-1, interferon-gamma, STAT1, chronic inflammation, azoxymethane/dextran sulfate sodium, tumor suppression
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Carrier Proteins, Cell Transformation, Neoplastic, Enzyme-Linked Immunosorbent Assay, Inflammation, Mice, Inbred C57BL, Blotting, Western, Colorectal Neoplasms, Cytokines, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Interleukin-18, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.